Activity and Effectiveness of Recombinant hEGF Excreted by Escherichia coli BL21 on Wound Healing in Induced Diabetic Mice.

Sriwidodo SriwidodoIman Permana MaksumToto SubrotoNasrul WathoniAnas SubarnasAbd Kakhar Umar

Published in: Journal of experimental pharmacology (2020)

Recombinant hEGF produced by extracellular secretion using E. coli BL21 has optimal diabetic wound healing activity through increased fibroblast proliferation.

Keyphrases

wound healing
escherichia coli
randomized controlled trial

systematic review
high glucose
signaling pathway

cell free
staphylococcus aureus
klebsiella pneumoniae

drug induced
pseudomonas aeruginosa